The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of targeted therapy in patients with advanced non-small cell lung cancer in response to broad genomic profiling.
 
Xiao Wang
No Relationships to Disclose
 
Jessica Long
No Relationships to Disclose
 
John Rothen
No Relationships to Disclose
 
Sida Huang
No Relationships to Disclose
 
Pamela Soulos
No Relationships to Disclose
 
Timothy Robinson
No Relationships to Disclose
 
Carolyn Presley
Consulting or Advisory Role - Bristol-Myers Squibb/Pfizer; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Onc Live; Regeneron
 
Sarah Goldberg
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer; Daiichi Sankyo; Janssen; Lilly; Merck; Regeneron; Summit Therapeutics; Synthekine
Research Funding - Adela; Agenus (Inst); Amgen (Inst); AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Genentech (Inst); Merck (Inst); Mirati Therapeutics; ORIC Pharmaceuticals (Inst); Pfizer (Inst); Spectrum Pharmaceuticals (Inst); Vitrak (Inst)
 
Ronac Mamtani
Honoraria - Flatiron Health
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Genentech/Roche; Merck; Seattle Genetics/Astellas
Research Funding - Astellas Pharma (Inst); Merck
Expert Testimony - King and Spalding LLP; McBrayer Firm
 
Steven Ma
Consulting or Advisory Role - Servier
 
Shi-Yi Wang
No Relationships to Disclose
 
Natalia Kunst
No Relationships to Disclose
 
Michaela Dinan
Research Funding - AstraZeneca (Inst); Janssen (I)
 
Cary Gross
Research Funding - AstraZeneca (Inst); Johnson & Johnson (Inst)